CMG Pharmaceutical Co Ltd
KOSDAQ:058820
CMG Pharmaceutical Co Ltd
Research & Development
CMG Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
|
Research & Development
-₩1.5B
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-17%
|
|
|
Yuhan Corp
KRX:000100
|
Research & Development
-₩197B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-19%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Research & Development
-₩162.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Research & Development
-₩189.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Research & Development
-₩8.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Research & Development
-₩5.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
CMG Pharmaceutical Co Ltd
Glance View
CMG Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical drugs. The company is headquartered in Seoul, Seoul and currently employs 243 full-time employees. The company went IPO on 2001-08-31. The Company’s products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. The company is also engaged in the manufacture of stone products. The firm mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.
See Also
What is CMG Pharmaceutical Co Ltd's Research & Development?
Research & Development
-1.5B
KRW
Based on the financial report for Sep 30, 2025, CMG Pharmaceutical Co Ltd's Research & Development amounts to -1.5B KRW.
What is CMG Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-17%
Over the last year, the Research & Development growth was -34%. The average annual Research & Development growth rates for CMG Pharmaceutical Co Ltd have been 22% over the past three years , 10% over the past five years , and -17% over the past ten years .
